Insider · CIK 0001727809
Mutya Harsch
Files at YARW (VYNE Therapeutics Inc.). First filing -, latest -.
Mutya Harsch files SEC Form 4 as officer at YARW (VYNE Therapeutics Inc.). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Mutya Harsch has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 8 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | YARW VYNE Therapeutics Inc. | FTax withholding Common Stock | -4,007 | $0.60 | $2,394 | 121,898 | Apr 2, 2026 |
| Dec 31, 2025 | YARW VYNE Therapeutics Inc. | FTax withholding Common Stock | -3,579 | $0.58 | $2,076 | 125,905 | Jan 5, 2026 |
| Sep 30, 2025 | YARW VYNE Therapeutics Inc. | FTax withholding Common Stock | -3,581 | $0.34 | $1,200 | 129,484 | Oct 2, 2025 |
| Jun 30, 2025 | YARW VYNE Therapeutics Inc. | FTax withholding Common Stock | -3,581 | $1.65 | $5,909 | 133,065 | Jul 2, 2025 |
| Jun 2, 2025 | YARW VYNE Therapeutics Inc. | AGrant or award Common Stock | +1,145 | $0.81 | $927 | 136,646 | Jun 3, 2025 |
| Mar 31, 2025 | YARW VYNE Therapeutics Inc. | FTax withholding Common Stock | -8,828 | $1.58 | $14k | 135,501 | Apr 2, 2025 |
| Jan 21, 2025 | YARW VYNE Therapeutics Inc. | AGrant or award Stock Option (right to buy)derivative | +230,000 | $0.00 | $0 | 230,000 | Jan 23, 2025 |
| Dec 31, 2024 | YARW VYNE Therapeutics Inc. | FTax withholding Common Stock | -4,697 | $3.35 | $16k | 144,329 | Jan 2, 2025 |
Questions about Mutya Harsch
Answered from the filings on this page, as of the latest one.
Is Mutya Harsch buying or selling?
Mutya Harsch has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Mutya Harsch's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Mutya Harsch has 0.
Where does Mutya Harsch file Form 4?
Mutya Harsch has filed Form 4 at YARW (VYNE Therapeutics Inc.) as CHIEF LEGAL OFFICER AND GC. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.